India, March 20 -- Caleres Inc. (CAL) will host a conference call at 10:00 AM ET on March 20, 2025, to discuss Q4 24 earnings results. To access the live webcast, log on to https://investor.caleres.c... Read More
India, March 20 -- NeueHealth, Inc. (NEUE), a healthcare company, on Thursday announced a narrower net loss attributable to shareholders, compared to loss attributable last year. Shares of NeueHealth... Read More
India, March 20 -- Gambling.com Group Ltd. (GAMB), while reporting higher fourth-quarter results above market estimates, on Thursday maintained its positive outlook for fiscal 2025. In pre-market act... Read More
India, March 20 -- A report released by the Federal Reserve Bank of Philadelphia on Thursday said regional manufacturing activity expanded overall but was less widespread in the month of March. The P... Read More
India, March 20 -- While reporting financial results for the fourth quarter on Thursday, sporting goods retailer Academy Sports and Outdoors, Inc. (ASO) initiated its earnings, adjusted earnings, net ... Read More
India, March 20 -- President Donald Trump has issued a memorandum saying it is the policy of his Government that hiring in foreign policy positions, like hiring in all other parts of the Government, s... Read More
India, March 20 -- Eurozone construction output increased for the fourth straight month in January, though at a slower pace, data from Eurostat showed on Thursday. Construction output rose 0.2 percen... Read More
India, March 20 -- The Bank of England maintained its benchmark rate on Thursday, amid intensifying uncertainty over global trade policy. The nine-member committee voted 8-1 to maintain the Bank Rate... Read More
India, March 20 -- While reporting financial results for the second quarter on Thursday, electronics manufacturer Jabil Inc. (JBL) raised its core earnings and net revenue guidance for the full-year 2... Read More
India, March 20 -- Plus Therapeutics (PSTV) announced the FDA has conditionally accepted the company's new proprietary name, REYOBIQ, for its lead therapeutic candidate. The company noted that REYOBIQ... Read More